paclitaxel has been researched along with Huntington Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badger, JD; Bortolon, R; Dyer, RB; Estévez, A; Heldebrant, MP; Kovtun, IV; McMurray, CT; Perez-Terzic, CM; Terzic, A; Trushina, E; Windebank, AJ; Yao, J | 1 |
Goto, J; Hazeki, N; Kanazawa, I; Nakamura, K | 1 |
2 other study(ies) available for paclitaxel and Huntington Disease
Article | Year |
---|---|
Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease.
Topics: Active Transport, Cell Nucleus; Cell Death; Cell Nucleus; Cell Survival; Cells, Cultured; Cytoplasm; Humans; Huntingtin Protein; Huntington Disease; Microtubules; Mutation; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Paclitaxel | 2003 |
Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.
Topics: Animals; Blotting, Western; Cell Nucleus; COS Cells; Cycloheximide; Cytochalasin D; Cytoplasm; Exons; Humans; Huntingtin Protein; Huntington Disease; Molecular Weight; Nerve Tissue Proteins; Nocodazole; Nuclear Proteins; Paclitaxel; Peptide Fragments; Peptides; Protein Binding; Recombinant Fusion Proteins; Time Factors; Transfection; Tunicamycin | 1999 |